Francois Lebel
Chief Tech/Sci/R&D Officer at SIRNAOMICS LTD.
Profile
Francois Lebel is currently the Chief Medical Officer at Sirnaomics Ltd.
He previously held positions as Vice President-Research & Development at Baxter International, Inc. from 2011 to 2012, Chief Medical Officer & Executive Vice President at Spectrum Pharmaceuticals, Inc. from 2018 to 2022, Chief Medical Officer and EVP-Research & Development at Alaunos Therapeutics, Inc. from 2013 to 2018, and Vice President-Medical & Scientific Affairs at Medimmune, Inc. from 2004 to 2006.
Dr. Lebel obtained undergraduate and doctorate degrees from the University of Ottawa.
Francois Lebel active positions
| Companies | Position | Start |
|---|---|---|
| SIRNAOMICS LTD. | Chief Tech/Sci/R&D Officer | 2023-07-27 |
Former positions of Francois Lebel
| Companies | Position | End |
|---|---|---|
| SPECTRUM PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 2022-12-30 |
| ALAUNOS THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2018-10-25 |
| BAXTER INTERNATIONAL INC. | Corporate Officer/Principal | 2012-06-30 |
| Medimmune, Inc. | Chief Tech/Sci/R&D Officer | 2006-08-31 |
Training of Francois Lebel
| University of Ottawa | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 4 |
|---|---|
| ALAUNOS THERAPEUTICS, INC. | Health Technology |
| BAXTER INTERNATIONAL INC. | Health Technology |
| SPECTRUM PHARMACEUTICALS, INC. | Health Technology |
| SIRNAOMICS LTD. | Health Technology |
| Private companies | 1 |
|---|---|
| Medimmune, Inc. | Health Technology |
- Stock Market
- Insiders
- Francois Lebel